Eterna Therapeutics Inc. (ERNA)
Market Closed
15 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
2. 17
+0.06
+2.8436%
Pre Market
$
+0.18 +8.2949% 2. 35
3.61M Market Cap
- P/E Ratio
- Div Yield
6,100 Volume
0 Eps
$ 2.11
Previous Close 
Want to track ERNA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ERNA Stock Shoots Up 140% in a Month: Here's What You Should Know
Ernexa Therapeutics stock soars 140% in a month as ERNA-101 shows complete tumor clearance and long-term survival in pre-clinical ovarian cancer models.
Zacks | 4 months ago
Ernexa Therapeutics Inc. (NASDAQ:ERNA) Short Interest Update
Ernexa Therapeutics Inc. (NASDAQ: ERNA - Get Free Report) saw a significant growth in short interest in the month of February. As of February 27th, there was short interest totaling 247,054 shares, a growth of 136.9% from the February 12th total of 104,299 shares. Currently, 3.3% of the company's shares are sold short. Based on an
Defenseworld | 7 months ago
2026 © Marketlog. All Rights Reserved.
